
Natera NTRA
$ 234.08
-0.62%
Quarterly report 2024-Q3
added 11-12-2024
Natera DPO Ratio 2011-2025 | NTRA
Annual DPO Ratio Natera
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 17.9 | 32.1 | 22.3 | 30.9 | 23.7 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 32.1 | 17.9 | 25.4 |
Quarterly DPO Ratio Natera
| 2024-Q3 | 2023-Q4 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | 17.3 | 18.4 | - | 19.6 | 19 | 25.4 | 33 | 33.7 | 34 | 27 | 22.1 | 23.2 | 23.1 | 27.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 34 | 17.3 | 24.9 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
125 | $ 20.97 | -1.38 % | $ 226 M | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
106 | $ 0.23 | -4.4 % | $ 6.75 M | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 39.53 | -1.4 % | $ 1.1 B | ||
|
BioNano Genomics
BNGO
|
104 | $ 1.52 | - | $ 1.93 M | ||
|
DarioHealth Corp.
DRIO
|
43.9 | $ 10.17 | 1.29 % | $ 289 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
DexCom
DXCM
|
70.4 | $ 67.51 | 0.13 % | $ 26.1 B | ||
|
Danaher Corporation
DHR
|
66.4 | $ 230.0 | -0.45 % | $ 168 B | ||
|
Exact Sciences Corporation
EXAS
|
139 | $ 101.56 | 0.02 % | $ 18.8 B | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
34.9 | $ 26.78 | -0.85 % | $ 810 M | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 19.47 | -1.32 % | $ 1.05 B | ||
|
Anixa Biosciences
ANIX
|
1.29 K | $ 3.21 | -6.25 % | $ 102 K | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
126 | $ 226.52 | 0.26 % | $ 41.1 B | ||
|
Guardant Health
GH
|
83.6 | $ 103.35 | 0.94 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
112 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
42 | $ 6.44 | -1.68 % | $ 583 M | ||
|
Illumina
ILMN
|
56.3 | $ 135.12 | -0.15 % | $ 21.5 B | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 203.88 | - | $ 10.5 B | ||
|
ENDRA Life Sciences
NDRA
|
1.65 K | $ 4.94 | -3.14 % | $ 2.65 M | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 7.12 | -0.35 % | $ 1.54 B | ||
|
National Research Corporation
NRC
|
10.1 | $ 18.74 | 0.46 % | $ 460 M | ||
|
Quest Diagnostics Incorporated
DGX
|
18.3 | $ 176.16 | 0.15 % | $ 19.6 B | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 | $ 254.32 | 0.02 % | $ 21.3 B | ||
|
ICON Public Limited Company
ICLR
|
6.52 | $ 182.75 | -0.51 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
27 | $ 688.22 | 0.01 % | $ 56.8 B | ||
|
Pacific Biosciences of California
PACB
|
33.5 | $ 1.77 | -5.85 % | $ 449 M | ||
|
Lantheus Holdings
LNTH
|
25.3 | $ 66.73 | 0.07 % | $ 4.62 B | ||
|
Mettler-Toledo International
MTD
|
53.4 | $ 1 419.64 | 0.11 % | $ 30.1 B | ||
|
Agilent Technologies
A
|
50.1 | $ 138.31 | 0.03 % | $ 42 B | ||
|
Biomerica
BMRA
|
32.4 | $ 2.7 | 1.9 % | $ 6.2 M | ||
|
Bioventus
BVS
|
59.2 | $ 7.4 | 0.27 % | $ 464 M | ||
|
NeoGenomics
NEO
|
20.7 | $ 12.33 | 0.2 % | $ 1.56 B |